Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Rang in aandelen #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Aandeelprijs
$4.06
Laatst gesynchroniseerd: 2024-02-23
Marktkapitalisatie
$145.61M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Theseus Pharmaceuticals, Inc. (THRX)

Categorie

Aandelsplitsingen voor Theseus Pharmaceuticals, Inc. (THRX)
Het aandeel Theseus Pharmaceuticals, Inc. (symbool: THRX) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 25, 2026.
Eén aandeel THRX dat vóór Aug 25, 2026 werd gekocht, staat nu gelijk aan 0 aandelen THRX.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH